The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Achievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1213829 · Cited by 979
Research works printed but not linked: 55
- Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet (London, England), 364, 685, 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
- Stone, 2010, Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries, Diabetes Res Clin Pract, 87, 252, 10.1016/j.diabres.2009.10.020 · DOI
- Soidán, 2010, Clinical practice guidelines in type 2 diabetes mellitus: similarities and discrepancies, Med Clin, 135
- Nathan, 2006, Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy, A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes, 29, 1963
- Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 2012;35(6):1364–79. · DOI · Paper page
- American Diabetes Association, 2017, Standards of medical care in diabetes—2017: summary of revisions, Diabetes Care, 40, S4, 10.2337/dc17-S003 · DOI · Paper page
- Ryden, 2013, Eur Heart J, 34, 3035, 10.1093/eurheartj/eht108 · DOI · Paper page
- Stone, 2013, Quality of care of people with type 2 diabetes in eight European Countries: findings from the guideline adherence to enhance care (GUIDANCE) study, Diabetes Care, 36, 2628, 10.2337/dc12-1759 · DOI · Paper page
- Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ (Clin Res ed.), 339, b2535, 10.1136/bmj.b2535 · DOI · Paper page
- Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
- Andrade JF, Silva V, Melnik T. Mulberry therapy for type 2 diabetes mellitus. Cochrane Database Syst Rev 2015(5). · DOI
- Ferket, 2010, Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?, Arch Intern Med, 170, 27, 10.1001/archinternmed.2009.434 · DOI · Paper page
- Ferket BS, Grootenboer N, Colkesen EB, Visser JJ, van Sambeek MRHM, Spronk S, et al. Systematic review of guidelines on abdominal aortic aneurysm screening. J Vasc Surg 55(5):1296–1304.e4. · DOI
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ (Clin Res ed.), 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ (Clin Res ed.), 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- Stark, 2011, Medical care of type 2 diabetes in German Disease Management Programmes: a population-based evaluation, Diabetes/Metab Res Rev, 27, 383, 10.1002/dmrr.1186 · DOI
- Davidson, 2008, A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients, Clin Ther, 30, 287, 10.1016/j.clinthera.2008.02.007 · DOI
- Bala, 2013, Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study, Pol Arch Med Wewn, 123, 573, 10.20452/pamw.1964 · doi:10.20452/pamw.1964
- Bala, 2011, Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study, Kardiologia polska, 69, 1249
- Bala, 2011, Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study, Pol Arch Med Wewn, 121, 7
- Miñambres, 2016, Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain, BMC Endocr Disord, 16, 10, 10.1186/s12902-016-0090-1 · DOI
- Vaccaro, 2008, The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy, Atherosclerosis, 198, 396, 10.1016/j.atherosclerosis.2007.10.026 · DOI
- Leśniak, 2015, Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study, Cardiol J, 22, 150, 10.5603/CJ.a2014.0067 · DOI
- Bala, 2014, Management and treatment goals in Polish patients with type 2 diabetes of more than ten years' duration – results of ARETAEUS2-Grupa Study, Endokrynologia Polska, 65, 158
- Al-Taweel, 2013, Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait, Int J Clin Pharm, 35, 244, 10.1007/s11096-012-9738-8 · DOI
- Issam Diab, 2013, Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar, Int J Clin Pharm, 35, 101, 10.1007/s11096-012-9714-3 · doi:10.1007/s11096-012-9714-3
- Mafauzy, 2011, The status of diabetes control in Malaysia: results of Diabcare 2008, Med J Malaysia, 66, 175
- Latif, 2011, Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008, Bangladesh Med Res Counc Bull, 37, 11, 10.3329/bmrcb.v37i1.7793 · DOI
- American Diabetes Association, 2005, Standards of medical care in diabetes–2006, Diabetes Care, 29, s4, 10.2337/diacare.28.suppl_1.S4 · DOI · Paper page
- Rao, 2015, Comparison of the adherence to the american diabetes association guidelines of diabetes care in primary care and subspecialty clinics, J Diabet Metab Disord, 14, 35, 10.1186/s40200-015-0158-x · DOI
- Al Harbi, 2015, Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia, Saudi Med J, 36, 221, 10.15537/smj.2015.2.9603 · DOI
- Ali, 2013, Evaluation of factors associated with inadequate glycemic control and some other health care indicators among patients with type 2 diabetes in Ramallah, Palestine, Res J Pharmaceut, Biol Chem Sci, 4, 445
- Meyer, 2010, Comanagement of elderly patients with type 2 diabetes: better adherence to ADA guidelines?, Osteopathic Family Phys, 2, 160, 10.1016/j.osfp.2010.04.001 · doi:10.1016/j.osfp.2010.04.001
- Rodríguez, 2011, Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study, Diabetic Med: J Brit Diabet Assoc, 28, 731, 10.1111/j.1464-5491.2011.03258.x · DOI
- UK Prospective Diabetes Study Group, 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39, BMJ (Clin Res ed.), 317, 713, 10.1136/bmj.317.7160.713 · DOI · Paper page
- Wild, 2004, Global prevalence of diabetes, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 · DOI · Paper page
- Oellgaard, 2017, Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits, Kidney Int, 91, 982, 10.1016/j.kint.2016.11.023 · DOI
- O'Connor, 1997, Differences between diabetic patients who do and do not respond to a diabetes care intervention: a qualitative analysis, Fam Med, 29, 424
- Grant, 2011, Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines, Diabetes Educ, 37, 78, 10.1177/0145721710388427 · DOI
- Farquhar, 2002, Clinicians' attitudes to clinical practice guidelines: a systematic review, Med J Australia, 177, 502, 10.5694/j.1326-5377.2002.tb04920.x · DOI · Paper page
- Cranney, 2001, Why do GPs not implement evidence-based guidelines? A descriptive study, Fam Pract, 18, 359, 10.1093/fampra/18.4.359 · DOI · Paper page
- Carlsen, 2007, Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines, Brit J Gen Pract: J R Coll Gen Practition, 57, 971, 10.3399/096016407782604820 · DOI · Paper page
- Cahn, 2015, Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists, Diabetes Care, 38, 2293, 10.2337/dc15-0187 · DOI
- Larme, 2001, Evidence-based guidelines meet the real world, Case Diabet Care, 24, 1728, 10.2337/diacare.24.10.1728 · DOI
- Hermans, 2013, Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial, Diabetes Care, 36, 3388, 10.2337/dc12-1853 · DOI
- Prior, 2008, The effectiveness of clinical guideline implementation strategies–a synthesis of systematic review findings, J Eval Clin Pract, 14, 888, 10.1111/j.1365-2753.2008.01014.x · DOI · Paper page
- Comin E, Catalan-Ramos A, Iglesias-Rodal M, Grau M, Del Val JL, Consola A, et al. Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors: a pre-post controlled study. Atencion primaria 2017. · DOI
- Simmons, 2017, Diabetologia, 60, 1016, 10.1007/s00125-017-4230-6 · DOI
- Ament SMC, de Groot JJA, Maessen JMC, Dirksen CD, van der Weijden T, Kleijnen J. Sustainability of professionals’ adherence to clinical practice guidelines in medical care: a systematic review. BMJ Open 2015;5(12). · DOI · Paper page
- Ji, 2013, Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables, BMC Publ Health, 13, 10.1186/1471-2458-13-602 · DOI
- Woodard, 2011, Impact of comorbidity type on measures of quality for diabetes care, Med Care, 49, 605, 10.1097/MLR.0b013e31820f0ed0 · DOI
- Engel, 2017, Adherence to cardiac practice guidelines in the management of non-st-elevation acute coronary syndromes: a systematic literature review, Curr Cardiol Rev, 13, 3, 10.2174/1573403X12666160504100025 · DOI
- Lian, 2014, Diabetes management in the real world and the impact of adherence to guideline recommendations, Curr Med Res Opin, 30, 2233, 10.1185/03007995.2014.952716 · DOI
- Wong, 2013, Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status, Diabetes Vasc Dis Res, 10, 505, 10.1177/1479164113496828 · DOI
Cited by
The Role of Inflammation in Diabetic Retinopathy
Forrester, J. V., Kuffova, L., & Delibegovic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 432
Aroda, V. R., Ahmann, A., Cariou, B., Chow, F., Davies, M. J., Jódar, E., Mehta, R., Woo, V., & Lingvay, I. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.12.001 · Cited by 296
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
Sinha, R., Papamargaritis, D., Sargeant, J. A., & Davies, M. J. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22067 · Cited by 138
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
De Block, C., Bailey, C., Wysham, C., Hemmingway, A., Allen, S. E., & Peleshok, J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14831 · Cited by 121
Daly, A. B., Boughton, C. K., Nwokolo, M., Hartnell, S., Wilinska, M. E., Cezar, A., Evans, M. L., & Hovorka, R. (2023) · Nature Medicine · doi:10.1038/s41591-022-02144-z · Cited by 120
Metadata
- Authors
- Khunti, K., Ceriello, A., Cos, X., & De Block, C.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 137
- Pages
- 137-148
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2784276839
- Cited by
- 200
- References
- 13
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care
- NIHR Leicester–Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. https://app.cochat.ai/papers/10.1016/j.diabres.2017.12.004
- The paper
- Khunti, K., Ceriello, A., Cos, X., & De Block, C. (2018). Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2017.12.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.